Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer
The current study is a prospective phase II study; Eligible patients will receive hypofractionated Irradiation at a total dose of 28.5Gy in 5 once-weekly fractions of 5.7Gy in 5 weeks to the Whole Breast or chest wall with or without peripheral lymphatic irradiation.
Breast Cancer|Radiotherapy Side Effect
RADIATION: Weekly hypofractionation for early breast cancer
Change in cosmetic breast appearance, according to HARVARD cosmesis scale: 1 Excellent, 2Good, 3 Fair and 4 Poor, six months|Acute radiation toxicity assessment, according to the RTOG acute toxicity scale: 0 No visible change, 1 faint/dull erythema, 2tender/ bright +- dry desquamation, 3 patchy moist desquamation, 4 conflueunt moist desquamation, pitting edema, 0 is the best and 4 is the worse., six months|Patient quality of life assessment., according to FACT-B, six months|Patient satisfaction., according to FACIT-TS-PS, six months
Testing the feasibility of a hypofractionated adjuvant radiotherapy regimen after breast surgery on a-once-weekly basis for a total dose of 28.5Gy in 5 fractions over 5 weeks in Kasr EL Aini Hospital.